Updated March 22 at 6:22pm
Biotechnology
38 results total, viewing 1 - 10
Cherrystone Angel Group this week said it has closed on a follow-on round with Kalion Inc., bringing its total investment in the industrial biotech company to $1 million. more
Two well-known, Rhode Island executives with expertise in medical innovation told the Interstate 195 Redevelopment District Commission Monday they want to create a new center to attract talent and spur business creation. more
Carol Malysz, the former head of the Center for Women & Enterprise Rhode Island, has been appointed executive director of MedMates, the life sciences technology networking group. more
Medley Genomics, a life sciences startup out of Brown University, has received $250,000 in seed funding from the Slater Technology Fund to build partnerships and demonstrate its concept with collaborators. more
(Updated, Dec. 19, 4:40 p.m.) EpiVax Inc. is part of a team that has been awarded a $1.87 million grant from Department of Defense’s Defense Threat Reduction Agency to develop an effective vaccine against a bacterium that leads to melioidosis, a tropical disease that is resistant to many antibiotics. more
Tedor Pharma Inc., a pharmaceutical development and manufacturing company, will double its production capacity this coming year with a multi-million dollar expansion. more
(Updated 9:23 a.m. and 4:23 p.m.) The I-195 Redevelopment District Commission authorized a series of incentives Monday to attract Wexford Science & Technology LLC, as well as the Cambridge Innovation Center, to two prime parcels of the former highway land. more
Alexion Pharmaceuticals Inc. has replaced its CEO and chief financial officer, the company’s board said Monday. more
Providence Business News recognized its 12 Business Excellence Award winners Thursday night at the Providence Marriott Downtown in front of a crowd of more than 200 people. more
Rhode Island ranked 35th in the nation for $1.6 million in venture capital investment in the third quarter, according to The MoneyTree Report by PricewaterhouseCoopers based on data from Thomson Reuters. more
1 | 2 | 3 | 4 Next »